Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy

Table 2 Tumor responses of fibrinogen to albumin ratio < 0.08 and fibrinogen to albumin ratio ≥ 0.08, n (%)

Variables	Low FAR (n = 123)	High FAR (n = 137)	χ2	P value
CR
0	121 (98.37)	136 (99.27)
1	2 (1.63)	1 (0.73)
PR
0	101 (82.11)	124 (90.51)
1	22 (17.89)	13 (9.49)
SD
0	86 (69.92)	104 (75.91)
1	37 (30.08)	33 (24.09)
PD
0	61 (49.59)	47 (34.31)
1	62 (50.41)	90 (65.69)
ORR			4.49	0.034
0	99 (80.49)	123 (89.78)
1	24 (19.51)	14 (10.22)
DCR			6.24	0.013
0	62 (50.41)	90 (65.69)
1	61 (49.59)	47 (34.31)

FAR: Fibrinogen-to-albumin ratio; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progression disease; ORR: Objective responds rates; DCR: Disease control rates.